Infectious Disease Therapeutics Market Revenue 2025 to 2034
Infectious Disease Therapeutics Market Revenue 2025 to 2034
Infectious Disease Therapeutics Market (By Mode of Treatment: Vaccines, Drugs; By Target Organism: Antifungal, Antiviral, Antibacterial, Anti-parasite, Others; By Infection Type: Viral, Parasitic, Fungal, Bacterial, Others; By Distribution Channel: Clinic, Hospitals, Others; By Region: North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 36.22 Bn
Forecast Year, 2034
USD 53.48 Bn
CAGR, 2025 - 2034
5.97%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The infectious disease therapeutics market is projected to grow from USD 36.22 billion in 2025 to USD 53.48 billion by 2034, at a CAGR of 5.97%. This growth is driven by advancements in treatment options and the increasing prevalence of infectious diseases globally.
Infectious Disease Therapeutics Market Size Analysis
Infectious Disease Therapeutics Market Size Mode of Treatment 2025 to 2034 (USD Billion)
| Mode of Treatment | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaccines | 16.32 | 17.13 | 18.46 | 19.30 | 20.69 | 21.57 | 23.21 | 24.57 | 25.92 | 27.38 |
| Drugs | 19.88 | 21.18 | 22.27 | 23.62 | 25.26 | 26.65 | 28.25 | 29.77 | 31.55 | 33.58 |
Infectious Disease Therapeutics Market Size Target Organism 2025 to 2034 (USD Billion)
| Target Organism | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Antifungal | 5.43 | 5.77 | 6.13 | 6.46 | 6.88 | 7.21 | 7.73 | 8.13 | 8.71 | 9.14 |
| Antiviral | 9.14 | 9.60 | 10.19 | 10.80 | 11.43 | 12.16 | 12.77 | 13.62 | 14.43 | 15.37 |
| Antibacterial | 14.46 | 15.26 | 16.24 | 17.23 | 18.15 | 19.31 | 20.63 | 21.80 | 23.20 | 24.32 |
| Anti-parasite | 3.59 | 3.82 | 4.04 | 4.34 | 4.58 | 4.82 | 5.09 | 5.39 | 5.72 | 6.07 |
| Others | 3.65 | 3.82 | 4.05 | 4.35 | 4.54 | 4.79 | 5.09 | 5.46 | 5.81 | 6.11 |
Infectious Disease Therapeutics Market Size Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 14.55 | 15.34 | 16.16 | 17.18 | 18.36 | 19.43 | 20.65 | 21.65 | 22.88 | 24.57 |
| Asia Pacific | 10.89 | 11.52 | 12.17 | 12.86 | 13.76 | 14.65 | 15.52 | 16.15 | 17.21 | 18.41 |
| Europe | 7.28 | 7.62 | 8.19 | 8.64 | 9.07 | 9.76 | 10.36 | 10.94 | 11.61 | 12.24 |
| LAMEA | 3.65 | 3.81 | 4.06 | 4.32 | 4.54 | 4.87 | 5.11 | 5.39 | 5.72 | 6.14 |
Infectious Disease Therapeutics Market Size to Surpass USD 53.48 Billion by 2034
The infectious disease therapeutics market size was evaluated at USD 36.22 billion in 2025 and is expected to grow around USD 53.48 billion by 2034 a CAGR of 5.97%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
